Arch Dis Child. Published Online First: 19 May 2009. doi:10.1136/adc.2008.148155
Leading articles |
Registration of Trials in Children. Update of Current International Initiatives
1 Mario Negri Pharmacological Research Institute, Italy
2 Derbyshire Children's Hospital, United Kingdom
* To whom correspondence should be addressed. E-mail: chiara{at}marionegri.it.
Accepted 5 May 2009
Abstract
The last few years have been characterized by an increasing awareness of the inadequacy of children’s therapeutic options and of science’s insufficient knowledge in the area. The well-documented, frequent use of off-label and unlicensed medications in the young, with the increased risks it carries, can be seen as an indicator of the still limited knowledge on paediatric drug therapies. This lack of data is generally due to the greater difficulties inherent (ethical, practical, and economic) in carrying out clinical trials in children. In such a context, given the scant evidence available on safety and efficacy of drug therapies, the use of drugs in children is often inappropriate (not rational).
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text (Rapid PDF)
-
All Versions of this Article:
adc.2008.148155v1
94/9/717 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
